Media Database
>
Deanna Macneil

Deanna Macneil

Author at the-scientist.com at The Scientist

Contact this person
Email address
d*****@*******.comGet email address
Influence score
32
Location
Canada
Languages
  • English
Covering topics

    View more media outlets and journalists by signing up to Prowly

    View latest data and reach out all from one place
    Sign up for free

    Recent Articles

    the-scientist.com

    Carving Out a Niche for Muscle Stem Cells with 3D Culture

    Carving Out a Niche for Muscle Stem Cells with 3D Culture
    the-scientist.com

    How Cells Know Where to Grow After Injury

    Fish fins and single-cell sequencing help scientists glean new insights into tissue regeneration.
    the-scientist.com

    How Sperm Regulate Offspring Health

    A short term high fat diet before fertilization rewires sperm small RNA expression, passing predisposition to metabolic disease onto offspring.
    the-scientist.com

    Small Model Organisms as Versatile Research Tools

    Flies, worms, and fish with rapid development and characterized genetics help scientists uncover fundamental and universal biological processes, and shape cutting-edge research across disciplines.
    the-scientist.com

    Automating In Vivo Screens and Challenging Dogma - The Scientist

    ABOVE: C. elegans are exceptional model organisms for in vivo compound screens. A new lab on a chip device builds on the benefits of C. elegans culture techniques while overcoming conventional challenges. ©istock, HeitiPaves Caenorhabditis elegans is a tiny nematode species that makes big contributions to molecular research. These worms have simple genomes, well-delineated developmental processes, brief lifespans, and many conserved biological pathways across the animal kingdom, including human…
    the-scientist.com

    Shifting Parturition Perspectives in Perinatology Research

    Nardhy Gómez-López investigates the placental immunology of preterm birth.
    the-scientist.com

    Measuring Mutagenesis with Precision Genome Editing - The Scientist

    ABOVE: Precise genome editing tools transform how researchers investigate cancer mutations. Owen Gould When scientists first began applying CRISPR for genome editing in human cells, it opened the floodgates for studying disease genetics. In those early days of editing with CRISPR-Cas9, precision oncology researcher Francisco Sánchez-Rivera was a graduate student investigating cancer genetics in Tyler Jacks’ laboratory at the Massachusetts Institute of Technology (MIT). In his graduate work, he…
    the-scientist.com

    MEGA CRISPR: Engineering Better Immunotherapies with RNA Editing

    ABOVE: Researchers edit RNA to bypass genome editing limitations in CAR T cell engineering. © iStock, libre de droit Many foundational research technologies have transformed cellular therapies, moving treatments from concept to clinic. In the past decade, chimeric antigen receptors (CAR) and genome editing are two standouts that led to breakthrough CAR T cell therapies for leukemia and lymphoma.1 Scientists engineer these treatments with virus-mediated gene insertion ex vivo, which instructs T…
    the-scientist.com

    Delivering Prime Editors With Virus-like Particles

    ABOVE: Virus-like particles combine advantages of viral and nonviral delivery methods for CRISPR gene editing. © iStock, DrAfter123 Much as a precious parcel cannot reach its destination without a reliable mail carrier, gene editors cannot make it to their target DNA without safe and effective delivery methods. Viral vectors and chemical approaches enable researchers to edit genomes in cell culture and in vivo with clustered regularly interspaced short palindromic repeats (CRISPR) and related…
    the-scientist.com

    Making Moves Toward Cell Therapy for Diabetes - The Scientist

    ABOVE: Scientists are working towards pancreatic islet transplants for diabetes treatment. © iStock, AlexLMX Insulin administration is the current mainstay of type 1 diabetes therapy, but it requires frequent injections and monitoring to provide patients with glycemic control.1 As cell therapies gain traction in the clinic for different disease states, researchers aim to optimize this approach for future diabetes treatments.2 Scientists are looking into islet transplantation as a promising alte…
    the-scientist.com

    Making Connections: Click Chemistry and Bioorthogonal Chemistry

    Simple, quick, and modular reactions allow researchers to create useful molecular structures from a wide range of substrates.
    the-scientist.com

    Placental Gene Expression Hints at Preterm Birth

    Researchers mapped out cellular changes in the maternal-fetal interface to uncover term and preterm labor complexities.
    the-scientist.com

    Researchers CHOOSE Organoids to Investigate Neurodevelopment - The ...

    ABOVE: Researchers connect neurodivergent genetics to developmental cell fates using brain organoid models, CRISPR, and single-cell RNA sequencing. ©i Stock, MarLei No two brains are the same. This is well known in life and science, but why brains develop divergently in autism spectrum disorder (ASD) is a mystery that persists in neurobiology research. Many genetic studies indicate that ASD likely arises early during fetal stages of development.1 However, researchers are still trying to connec…
    the-scientist.com

    How Plants Protect Their DNA in Space - The Scientist

    ABOVE: Scientists explored how Arabidopsis thaliana grown aboard the ISS protects its DNA. © iStock, dra_schwartz The NASA Twins Study published in 2019 compared biological changes in identical twin astronauts Scott and Mark Kelly.1 The former spent a year on the International Space Station (ISS) and the latter remained Earthside. Among other differences, Scott’s telomeres grew longer while he was in space and shortened once he returned to Earth.Like many researchers in the telomere field, Dor…
    the-scientist.com

    Addressing Power and Pitfalls in Machine Learning Neoantigen ... - ...

    Scientists train machine learning prediction models on massive datasets and fine-tune their predictions with transfer learning, which re-uses knowledge learned on one task to boost the power of a related task. © iStock, TavriusAntigen presentation by major histocompatibility complex (MHC) proteins is the caller ID of the immune system. On the cell surface, MHCs display peptides derived from cellular components or foreign sources such as viruses, bacteria, or parasites. Peptide display allows the…
    the-scientist.com

    CRISPR Gene Editing: Cas9 and Beyond

    Researchers create and improve CRISPR-Cas mediated gene editing technologies based on prokaryotic CRISPR systems and eukaryotic DNA repair mechanisms.
    the-scientist.com

    The Latest in Lab Automation

    As technologies advance, laboratory automation becomes reachable for researchers seeking high throughput approaches and reproducible results.
    the-scientist.com

    Relevant Models Reflect Real-world Needs

    Jie Sun shares how his curiosity, creativity, and motivation to address clinical public health needs steer his research in immunology and infectious disease.
    the-scientist.com

    The Bigger Protein Picture of Designing Parkinson's Therapeutics - ...

    Parkinson’s disease is the second most common neurodegenerative disorder, affecting more than ten million people worldwide. The breakdown of dopaminergic neurons in a brain region involved in movement, called the substantia nigra pars compacta, causes Parkinson’s disease symptoms, including tremors, impaired movement and stiffness, and disrupted balance. As the incidence of Parkinson’s disease continues to increase, this disorder places a large burden on patients, caregivers, and the healthcare…
    the-scientist.com

    Connecting the Dots That Link Diabetes and Infection Severity

    Researchers shed light on the immunometabolism of respiratory infection, providing an avenue towards safer COVID-19 therapeutics for those affected by metabolic disorders.
    the-scientist.com

    Post-Translational Control: The Next Step in Synthetic Circuits - T...

    Researchers engineer a protease-mediated post-translational path faster than gene switches for processes that need to happen quickly, such as insulin release.